mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Последние новости
⚑ Сообщить о проблемеTech news from the best sources
Все темы
- игры
AI
Gear
News
Tech
agents
ai
api
architecture
automation
beginners
career
database
devops
javascript
llm
machinelearning
mcp
opensource
performance
productivity
programming
python
react
security
showdev
testing
tutorial
typescript
webdev
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
In February, a Trump official refused to review the vaccine.
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.